Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 8Cholangiocarcinoma 7Carcinoma, Hepatocellular 7Liver Neoplasms 5Klatskin Tumor 4Fibrosis 4Neoplasm Metastasis 3Neoplasms 2Liver Diseases 2Hypertension, Portal 2Bile Duct Neoplasms 2Reperfusion Injury 1Rejection, Psychology 1Recurrence 1PRETEXT I Hepatoblastoma 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Colorectal Liver Metastases 1Colonic Neoplasms 1Cholangitis, Sclerosing 1

Interventions

Imatinib Mesylate 67Sunitinib 27nilotinib 14regorafenib 13ripretinib 10avapritinib 5Ipilimumab 5Dasatinib 5spartalizumab 4Laparoscopy 4CTLA-4 Antigen 44-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 4pexidartinib 3pazopanib 3binimetinib 3Temozolomide 3Paclitaxel 3Oxaliplatin 3Nivolumab 3Midazolam 3Leucovorin 3Gemcitabine 3Bevacizumab 3trametinib 2tanespimycin 2ponatinib 2pembrolizumab 2masitinib 2famitinib 2envafolimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Gastrointestinal Stromal Tumors × Liver Transplantation × Clear all
NCT04825470 2022-03-11

TRANSGIST

Hospital Universitario Virgen de la Arrixaca

Phase NA Unknown
50 enrolled
GastrointestinalSarcoma

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasm Metastasis, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡